首页> 外文期刊>Human Immunology: Official Journal of the American Society for Histocompatibility and Immunogenetics >DTT TREATMENT OF SERA IS EFFECTIVE IN REMOVING INTERFERENCE BY THE C1 COMPONENT OF COMPLEMENT IN SINGLE ANTIGEN AND C1Q ASSAYS

【24h】

DTT TREATMENT OF SERA IS EFFECTIVE IN REMOVING INTERFERENCE BY THE C1 COMPONENT OF COMPLEMENT IN SINGLE ANTIGEN AND C1Q ASSAYS

机译：血清的DTT治疗有效消除单一抗原和C1Q分析中的C1补体成分的干扰

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Human Immunology: Official Journal of the American Society for Histocompatibility and Immunogenetics》 |2013年第5期|共1页
作者
Spanjer Katharine; Freed Brian; Greenlee Kelly; Cagle Linda; Hedlund Garrett; Swensen Zachary; McLaughlin Dianne; Bruno Sarah; McCormick Lindsay; Blackburn Kristen; Schultz Kristen;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词

相似文献

外文文献
中文文献
专利

1. DTT TREATMENT OF SERA IS EFFECTIVE IN REMOVING INTERFERENCE BY THE C1 COMPONENT OF COMPLEMENT IN SINGLE ANTIGEN AND C1Q ASSAYS [J] . Spanjer Katharine, Freed Brian, Greenlee Kelly, Human Immunology: Official Journal of the American Society for Histocompatibility and Immunogenetics . 2013,第5期

机译：血清的DTT治疗有效消除单一抗原和C1Q分析中的C1补体成分的干扰
2. THE COMPLEMENT INTERFERENCE EFFECT IN HLA ANTIBODY DETECTION IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS: A VALIDATION STUDY OF EDTA TREATMENT IN LABSCREEN PRA AND SINGLE ANTIGEN ASSAY [J] . Zou Jun, Barnes Titus, Lopez Asdrubal, Human Immunology: Official Journal of the American Society for Histocompatibility and Immunogenetics . 2017,第Suppla1期

机译：造血干细胞移植患者HLA抗体检测中的补体干扰效应：耐药症PRA和单抗原测定中EDTA治疗的验证研究
3. THE COMPLEMENT INTERFERENCE EFFECT IN HLA ANTIBODY DETECTION IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS: A VALIDATION STUDY OF EDTA TREATMENT IN LABSCREEN PRA AND SINGLE ANTIGEN ASSAY [J] . Zou Jun, Barnes Titus, Lopez Asdrubal, Human Immunology: Official Journal of the American Society for Histocompatibility and Immunogenetics . 2017,第Suppla1期

机译：造血干细胞移植患者HLA抗体检测中的补体干扰效应：耐药症PRA和单抗原测定中EDTA治疗的验证研究
4. ANALYSIS OF TYPING SERA BY C1Q AND IGG LUMINEX ASSAYS, CORRELATION WITH COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY. [C] . Marcelo Pando, Ge Chen, Flavia Sequeira, Clinical Histocompatibility Workshop. . 2010

机译：C1Q和IgG Luminex测定键入血清的分析，与补体依赖性淋巴细胞毒性测定的相关性。
5. A novel approach to control and regulate the classical complement pathway: Highly specific inhibition of C1q globular head binding to human IgG using an engineered single chain antibody variable fragment; recruiting C1q to HER2 /neu positive cells using truncated bispecific antibodies [D] . Hwang, Hee Young 2007

机译：一种控制和调节经典补体途径的新方法：使用工程化的单链抗体可变片段高度特异性地抑制C1q球头与人IgG的结合；使用截短的双特异性抗体将C1q募集到HER2 / neu阳性细胞
6. The primary complement components contained in circulating immune complexes in oligoarticular and polyarticular juvenile idiopathic arthritis patient sera are C1q and C4: evidence of classical complement activation [O] . Brooke E Gilliam, Melinda R Reed, Anil K Chauhan, 2012

机译：少关节和多关节青少年特发性关节炎患者血清中循环免疫复合物中所含的主要补体成分为C1q和C4：经典补体激活的证据
7. The reconstitution of human C1, the first complement component Binding of C1r and C1s to C1q influences the C1q conformation [O] . Golan Mario D., Hitschold Thomas, Loos Michael 1981

机译：人C1的重构，C1r和C1s与C1q的第一个补体成分结合会影响C1q构象

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号